Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versaclozâ„¢ (clozapine, USP) Oral Suspension

[PR Newswire] – DUBLIN, Feb. 11, 2014 /PRNewswire/ — Jazz Pharmaceuticals plc (JAZZ) today announced U.S. commercial availability of Versaclozâ„¢ (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-r more

View todays social media effects on JAZZ

View the latest stocks trending across Twitter. Click to view dashboard

See who Jazz is hiring next, click here to view